 |
|
|
Important Notice: The Forum does not endorse any medical
product or therapy. ALL medications and supplements
should be taken ONLY under the supervision of a physician,
due to the possibility of side-effects, drug interactions,
etc.
|
Name:
|
NS2330
|
|
Other Names:
|
Tesofensine
|
|
Development Status:
|
investigational in U.S.
|
|
FDA Phase:
|
Discontinued
|
|
Role in Alzheimer's Disease:
|
The compound enhances the function of the neurotransmitters
acetylcholine, noradrenaline and dopamine, which are all
impaired in Alzheimer's patients.
|
|
Companies:
|
Neurosearch A/S
|
|
Notes:
|
Cooperative Phase IIb Study with Boehringer Ingleheim.
400 patients with mild to moderate Alzheimer disease in the
U.S. and Canada.
This record was last updated Dec 19, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Participate in Research
See a list of research studies, projects, and clinical trials in search of research participants.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
